SPARK-BIH Venture Capital Day

08:30 till 15:00 o'clock
Kalendereintrag speichern
Berlin
The SPARK-BIH Venture Capital Day brings together a curated selection of startups, as well as late stage-stage academic and clinical innovation teams, industry leaders and venture capitalists from the global SPARK network, showcasing cutting-edge projects in therapeutics, medical devices, diagnostics, and digital health in front of a panel of invited venture capitalists and industry leaders.

     

     


    SPARK-BIH VC Day offers a unique opportunity to: 

    • Discover high-potential innovations at the intersection of science and medicine
    • Connect directly with academic entrepreneurs and translational researchers
    • Gain early access to projects supported by the SPARK ecosystem 

     

     

     



    Preliminary agenda subject to changes

    08:30

    Registration

    09:00

    Welcome and program overview

    09:10

    Pitch 1 – Therapeutics

    New Orphan Drug (YA-101) for Unmet Need: Multiple System Atrophy
    Yoda Pharmaceuticals, Inc.
    Taiwan

    09:20

    Pitch 2 – Therapeutics

    Nanoparticle-Based Inflammation Resolving Therapy
    Evolution Therapeutics
    UK

    09:30

    Pitch 3 – Therapeutics

    Conditionally activated anti-EGFR antibody for HNC and mCRC
    PreciseMD Biotech Co. Ltd.
    Taiwan

    09:40

    Pitch 4 – Therapeutics

    Biased STING Agonists to Enhance Resolving Inflammation and Tissue Fibrosis While Promoting Tissue Repair
    BiSTherapy
    Haifa - Israel

    09:50

    Pitch 5 – Therapeutics

    NuPLUS: A Rare Disease Solution for Metastatic Triple-Negative Breast Cancer
    NuPlus
    Taiwan

    10:00

    Pitch 6 – Therapeutics

    CyF-001: First-in-Class Dual-Action Oral Therapy for Secondary Stroke Prevention in Antiplatelet-Resistant Patients
    CyFthera
    Berlin - Germany

    10:10

    Pitch 7 – Therapeutics

    NanoX Platform Technology: LNP Cisplatin for Solid Cancer Treatments
    NanoX
    Taiwan

    10:20

    Pitch 8 – Therapeutics

    Fibraxis: Novel Inhalable Targeting Lung Structure in Asthma
    Fibraxis Ltd.
    UK

    10:30

    Coffee Break

    11:00

    Pitch 9 - Medical Devices

    Apateya: Revolutionizing Chronic Neuropathic Pain Treatment
    Apateya
    Bordeaux - France

    11:20

    Pitch 11 - Medical Devices

    iPreg: Biochip for Healthy Sperm Selection
    iPreg
    Taiwan

    11:30

    Pitch 12 - Medical Devices

    A Novel Pseudo-Skin Platform for Advanced Healing of Chronic
    Infected Wounds
    WITS Advanced Drug Delivery Platform
    South Africa - Africa

    11:40

    Pitch 13 - Medical Devices

    Prediction of Treatment Response in Liver Cancer
    BeLiver
    Bordeaux - France

    11:50

    Pitch 14 - Medical Devices

    Electrical Impedance Tomography: A 3D Noninvasive Visualization
    for Lymphedema Diagnosis
    Chiba University
    Tsukuba - Japan

    12:00

    Pitch 15 - Medical Devices

    Creating a Scalable, Radiation-Free Platform for Early
    Identification of Spinal Deformities in Youth
    SmileCurve
    Keio - Japan

    12:10

    Pitch 16 - Medical Devices

    LAMInEar: Laser-Assisted Minimally Invasive Drug Delivery to the
    Inner Ear
    LAMInEar
    Bordeaux - France

    12:20

    Pitch 17 - Diagnostics

    Functional Immune Profiling for Rapid Diagnosis of Primary HLH
    T-yp
    Zurich - Switzerland

    12:30

    Lunch Break

    13:30

    Pitch 18 - Therapeutics

    First-in-class AAV Gene Therapy for DFNA10 (EYA4) Using an Infiltrating Microneedle DDS for Atraumatic, Apex-Reaching
    Cochlear Delivery — an “Orphan --> Common” Path Toward EYA4- Linked Age-Related Hearing Loss
    Kitasato University & TUAT
    Kitasato - Japan

    13:40

    Pitch 19 - Therapeutics

    Next-Generation Novel Low-Contractility Hernia Mesh with
    ‘Superior Anti-Adhesion Properties
    Shanghai Jiao Tong University
    China

    13:50

    Pitch 20 - Therapeutics

    Engineering Macrophages to Treat Cardiac Muscle Calcification
    Amrita University
    Amrita - India

    14:00

    Pitch 21 - Therapeutics

    ADC for TNBC Targeting a New Antigen & Prediction Platform for
    Gastric Cancer
    The Kitasato Institute
    Kitasato - Japan

    14:10

    Pitch 22 - Therapeutics

    Next-Generation Biomedical Hydrogel for Postoperative Wound
    Sealing and Repair
    Shanghai Jiao Tong University
    China

    14:20

    Pitch 23 - Medical Devices

    Highly Affordable Insulin Pump and Hybrid-Closed Loop Artificial
    Pancreas System
    Amrita University & Indian Institute of Science
    Amrita - India

    14:30

    Pitch 24 - Diagnostics

    Development of Affordable POT (Point of Testing) Devices for
    Monitoring of AMR in Clinical and Environmental Settings
    Amrita University
    Amrita - India

    14:40

    Closing Remarks



     

     

    Find out more about the presenting teams and their projects. 

     



    Zurück zur Übersicht